nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2B6—malignant glioma	0.357	0.54	CbGaD
Bupropion—SLC6A3—malignant glioma	0.304	0.46	CbGaD
Bupropion—CYP1A2—Carmustine—malignant glioma	0.0819	0.57	CbGbCtD
Bupropion—CYP3A4—Temozolomide—malignant glioma	0.0619	0.431	CbGbCtD
Bupropion—Wound infection—Temozolomide—malignant glioma	0.00428	0.0371	CcSEcCtD
Bupropion—ORM1—vertebral column—malignant glioma	0.00318	0.178	CbGeAlD
Bupropion—SLC6A3—telencephalic ventricle—malignant glioma	0.00245	0.137	CbGeAlD
Bupropion—Sensory disturbance—Temozolomide—malignant glioma	0.00227	0.0196	CcSEcCtD
Bupropion—Hyperacusis—Temozolomide—malignant glioma	0.00189	0.0163	CcSEcCtD
Bupropion—Paranoid reaction—Carmustine—malignant glioma	0.00171	0.0148	CcSEcCtD
Bupropion—Impaired healing—Carmustine—malignant glioma	0.00168	0.0146	CcSEcCtD
Bupropion—Altered state of consciousness—Temozolomide—malignant glioma	0.00152	0.0132	CcSEcCtD
Bupropion—Cerebration impaired—Temozolomide—malignant glioma	0.0012	0.0103	CcSEcCtD
Bupropion—CHRNA3—retina—malignant glioma	0.00116	0.0649	CbGeAlD
Bupropion—Aphasia—Carmustine—malignant glioma	0.00112	0.00971	CcSEcCtD
Bupropion—Cyst—Carmustine—malignant glioma	0.00109	0.00942	CcSEcCtD
Bupropion—Tooth disorder—Temozolomide—malignant glioma	0.00108	0.00938	CcSEcCtD
Bupropion—Parosmia—Temozolomide—malignant glioma	0.00108	0.00938	CcSEcCtD
Bupropion—Aphasia—Temozolomide—malignant glioma	0.00108	0.00938	CcSEcCtD
Bupropion—Hypokinesia—Carmustine—malignant glioma	0.00108	0.00933	CcSEcCtD
Bupropion—Paranoia—Carmustine—malignant glioma	0.00107	0.00924	CcSEcCtD
Bupropion—Digestion impaired—Temozolomide—malignant glioma	0.00105	0.0091	CcSEcCtD
Bupropion—Apathy—Temozolomide—malignant glioma	0.000984	0.00852	CcSEcCtD
Bupropion—Influenza-like symptoms—Temozolomide—malignant glioma	0.000984	0.00852	CcSEcCtD
Bupropion—Flat affect—Temozolomide—malignant glioma	0.000975	0.00844	CcSEcCtD
Bupropion—Vaginal haemorrhage—Temozolomide—malignant glioma	0.000949	0.00822	CcSEcCtD
Bupropion—Hepatotoxicity—Carmustine—malignant glioma	0.000942	0.00815	CcSEcCtD
Bupropion—Herpes zoster—Temozolomide—malignant glioma	0.000933	0.00808	CcSEcCtD
Bupropion—Extrapyramidal disorder—Temozolomide—malignant glioma	0.000933	0.00808	CcSEcCtD
Bupropion—Hepatotoxicity—Temozolomide—malignant glioma	0.00091	0.00788	CcSEcCtD
Bupropion—Memory impairment—Temozolomide—malignant glioma	0.000895	0.00775	CcSEcCtD
Bupropion—Hyperaesthesia—Temozolomide—malignant glioma	0.000895	0.00775	CcSEcCtD
Bupropion—Rigors—Temozolomide—malignant glioma	0.000861	0.00745	CcSEcCtD
Bupropion—Liver injury—Temozolomide—malignant glioma	0.000835	0.00723	CcSEcCtD
Bupropion—Accidental injury—Carmustine—malignant glioma	0.000822	0.00712	CcSEcCtD
Bupropion—Disturbance in attention—Temozolomide—malignant glioma	0.000811	0.00702	CcSEcCtD
Bupropion—Amenorrhoea—Temozolomide—malignant glioma	0.0008	0.00693	CcSEcCtD
Bupropion—Thinking abnormal—Carmustine—malignant glioma	0.000794	0.00688	CcSEcCtD
Bupropion—Leukocytosis—Carmustine—malignant glioma	0.000774	0.0067	CcSEcCtD
Bupropion—Hepatic enzyme increased—Temozolomide—malignant glioma	0.000743	0.00643	CcSEcCtD
Bupropion—Coordination abnormal—Carmustine—malignant glioma	0.000741	0.00641	CcSEcCtD
Bupropion—Hearing impaired—Temozolomide—malignant glioma	0.000738	0.00639	CcSEcCtD
Bupropion—Neck pain—Carmustine—malignant glioma	0.000736	0.00637	CcSEcCtD
Bupropion—Pulmonary embolism—Carmustine—malignant glioma	0.000727	0.0063	CcSEcCtD
Bupropion—Coordination abnormal—Temozolomide—malignant glioma	0.000716	0.0062	CcSEcCtD
Bupropion—Musculoskeletal pain—Temozolomide—malignant glioma	0.000711	0.00616	CcSEcCtD
Bupropion—Vaginal inflammation—Temozolomide—malignant glioma	0.000703	0.00609	CcSEcCtD
Bupropion—Pulmonary embolism—Temozolomide—malignant glioma	0.000703	0.00609	CcSEcCtD
Bupropion—Urinary incontinence—Carmustine—malignant glioma	0.000702	0.00608	CcSEcCtD
Bupropion—Depressed level of consciousness—Carmustine—malignant glioma	0.000702	0.00608	CcSEcCtD
Bupropion—Neuropathy—Carmustine—malignant glioma	0.000683	0.00591	CcSEcCtD
Bupropion—Influenza like illness—Temozolomide—malignant glioma	0.000682	0.00591	CcSEcCtD
Bupropion—Depressed level of consciousness—Temozolomide—malignant glioma	0.000679	0.00588	CcSEcCtD
Bupropion—Urinary incontinence—Temozolomide—malignant glioma	0.000679	0.00588	CcSEcCtD
Bupropion—Coma—Carmustine—malignant glioma	0.000664	0.00575	CcSEcCtD
Bupropion—Vaginal infection—Temozolomide—malignant glioma	0.000663	0.00574	CcSEcCtD
Bupropion—SLC6A3—brainstem—malignant glioma	0.000662	0.0372	CbGeAlD
Bupropion—Neuropathy—Temozolomide—malignant glioma	0.00066	0.00571	CcSEcCtD
Bupropion—Neoplasm—Carmustine—malignant glioma	0.000657	0.00569	CcSEcCtD
Bupropion—Gynaecomastia—Carmustine—malignant glioma	0.000651	0.00563	CcSEcCtD
Bupropion—Dry eye—Temozolomide—malignant glioma	0.000649	0.00562	CcSEcCtD
Bupropion—Neoplasm—Temozolomide—malignant glioma	0.000635	0.0055	CcSEcCtD
Bupropion—Mental disability—Carmustine—malignant glioma	0.000631	0.00546	CcSEcCtD
Bupropion—Phlebitis—Carmustine—malignant glioma	0.000613	0.00531	CcSEcCtD
Bupropion—Mental disability—Temozolomide—malignant glioma	0.00061	0.00528	CcSEcCtD
Bupropion—CHRNA3—central nervous system—malignant glioma	0.000604	0.0339	CbGeAlD
Bupropion—Ear pain—Temozolomide—malignant glioma	0.000598	0.00518	CcSEcCtD
Bupropion—CHRNA3—cerebellum—malignant glioma	0.000591	0.0332	CbGeAlD
Bupropion—SLC6A3—telencephalon—malignant glioma	0.000588	0.033	CbGeAlD
Bupropion—Eye pain—Carmustine—malignant glioma	0.000585	0.00506	CcSEcCtD
Bupropion—Gastroenteritis—Temozolomide—malignant glioma	0.000576	0.00498	CcSEcCtD
Bupropion—Injury—Carmustine—malignant glioma	0.000574	0.00497	CcSEcCtD
Bupropion—Deafness—Temozolomide—malignant glioma	0.00057	0.00494	CcSEcCtD
Bupropion—Eye pain—Temozolomide—malignant glioma	0.000565	0.00489	CcSEcCtD
Bupropion—Amnesia—Carmustine—malignant glioma	0.000562	0.00486	CcSEcCtD
Bupropion—Nasal congestion—Temozolomide—malignant glioma	0.00056	0.00485	CcSEcCtD
Bupropion—Hot flush—Temozolomide—malignant glioma	0.000545	0.00472	CcSEcCtD
Bupropion—Amnesia—Temozolomide—malignant glioma	0.000543	0.0047	CcSEcCtD
Bupropion—Menopausal symptoms—Temozolomide—malignant glioma	0.000541	0.00468	CcSEcCtD
Bupropion—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000541	0.00468	CcSEcCtD
Bupropion—Thirst—Temozolomide—malignant glioma	0.000536	0.00464	CcSEcCtD
Bupropion—SLC6A2—brainstem—malignant glioma	0.000534	0.03	CbGeAlD
Bupropion—Diplopia—Carmustine—malignant glioma	0.000528	0.00457	CcSEcCtD
Bupropion—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000528	0.00457	CcSEcCtD
Bupropion—Diplopia—Temozolomide—malignant glioma	0.00051	0.00442	CcSEcCtD
Bupropion—Face oedema—Carmustine—malignant glioma	0.00051	0.00441	CcSEcCtD
Bupropion—Affect lability—Temozolomide—malignant glioma	0.000502	0.00435	CcSEcCtD
Bupropion—Ataxia—Carmustine—malignant glioma	0.000496	0.0043	CcSEcCtD
Bupropion—Face oedema—Temozolomide—malignant glioma	0.000492	0.00426	CcSEcCtD
Bupropion—Mood swings—Temozolomide—malignant glioma	0.000483	0.00418	CcSEcCtD
Bupropion—CHRNA3—brain—malignant glioma	0.00048	0.0269	CbGeAlD
Bupropion—Ataxia—Temozolomide—malignant glioma	0.00048	0.00415	CcSEcCtD
Bupropion—Dehydration—Temozolomide—malignant glioma	0.000474	0.00411	CcSEcCtD
Bupropion—SLC6A2—telencephalon—malignant glioma	0.000474	0.0266	CbGeAlD
Bupropion—Dry skin—Temozolomide—malignant glioma	0.000468	0.00405	CcSEcCtD
Bupropion—Muscular weakness—Carmustine—malignant glioma	0.000466	0.00403	CcSEcCtD
Bupropion—Breast disorder—Temozolomide—malignant glioma	0.000461	0.00399	CcSEcCtD
Bupropion—Dysphagia—Carmustine—malignant glioma	0.000456	0.00395	CcSEcCtD
Bupropion—Muscular weakness—Temozolomide—malignant glioma	0.00045	0.0039	CcSEcCtD
Bupropion—Abdominal distension—Temozolomide—malignant glioma	0.000444	0.00384	CcSEcCtD
Bupropion—ORM1—spinal cord—malignant glioma	0.000443	0.0249	CbGeAlD
Bupropion—Dysphagia—Temozolomide—malignant glioma	0.000441	0.00382	CcSEcCtD
Bupropion—Pancytopenia—Carmustine—malignant glioma	0.000433	0.00375	CcSEcCtD
Bupropion—Sweating increased—Temozolomide—malignant glioma	0.000429	0.00372	CcSEcCtD
Bupropion—Bronchitis—Temozolomide—malignant glioma	0.000424	0.00367	CcSEcCtD
Bupropion—SLC6A3—midbrain—malignant glioma	0.000422	0.0237	CbGeAlD
Bupropion—Pancytopenia—Temozolomide—malignant glioma	0.000419	0.00363	CcSEcCtD
Bupropion—Dysuria—Temozolomide—malignant glioma	0.000412	0.00357	CcSEcCtD
Bupropion—SLC6A3—spinal cord—malignant glioma	0.000412	0.0231	CbGeAlD
Bupropion—Hyperglycaemia—Carmustine—malignant glioma	0.000412	0.00356	CcSEcCtD
Bupropion—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00041	0.00355	CcSEcCtD
Bupropion—Pneumonia—Carmustine—malignant glioma	0.000409	0.00354	CcSEcCtD
Bupropion—Pollakiuria—Temozolomide—malignant glioma	0.000407	0.00353	CcSEcCtD
Bupropion—Erectile dysfunction—Temozolomide—malignant glioma	0.000406	0.00352	CcSEcCtD
Bupropion—Photosensitivity reaction—Temozolomide—malignant glioma	0.000402	0.00348	CcSEcCtD
Bupropion—Weight increased—Temozolomide—malignant glioma	0.000401	0.00347	CcSEcCtD
Bupropion—Weight decreased—Temozolomide—malignant glioma	0.000399	0.00345	CcSEcCtD
Bupropion—Neuropathy peripheral—Carmustine—malignant glioma	0.000399	0.00345	CcSEcCtD
Bupropion—Hyperglycaemia—Temozolomide—malignant glioma	0.000398	0.00344	CcSEcCtD
Bupropion—Stomatitis—Carmustine—malignant glioma	0.000397	0.00343	CcSEcCtD
Bupropion—Urinary tract infection—Carmustine—malignant glioma	0.000395	0.00342	CcSEcCtD
Bupropion—Pneumonia—Temozolomide—malignant glioma	0.000395	0.00342	CcSEcCtD
Bupropion—Infestation—Temozolomide—malignant glioma	0.000393	0.0034	CcSEcCtD
Bupropion—Infestation NOS—Temozolomide—malignant glioma	0.000393	0.0034	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00039	0.00337	CcSEcCtD
Bupropion—CYP2A6—cerebellum—malignant glioma	0.000386	0.0217	CbGeAlD
Bupropion—Neuropathy peripheral—Temozolomide—malignant glioma	0.000385	0.00334	CcSEcCtD
Bupropion—Stomatitis—Temozolomide—malignant glioma	0.000383	0.00332	CcSEcCtD
Bupropion—Urinary tract infection—Temozolomide—malignant glioma	0.000382	0.00331	CcSEcCtD
Bupropion—SLC6A2—medulla oblongata—malignant glioma	0.000373	0.0209	CbGeAlD
Bupropion—Sinusitis—Temozolomide—malignant glioma	0.000369	0.00319	CcSEcCtD
Bupropion—Haemoglobin—Carmustine—malignant glioma	0.000367	0.00318	CcSEcCtD
Bupropion—Haemorrhage—Carmustine—malignant glioma	0.000365	0.00316	CcSEcCtD
Bupropion—Hypoaesthesia—Carmustine—malignant glioma	0.000363	0.00315	CcSEcCtD
Bupropion—Hallucination—Carmustine—malignant glioma	0.000363	0.00315	CcSEcCtD
Bupropion—Oedema peripheral—Carmustine—malignant glioma	0.00036	0.00311	CcSEcCtD
Bupropion—ORM1—central nervous system—malignant glioma	0.000359	0.0202	CbGeAlD
Bupropion—Connective tissue disorder—Carmustine—malignant glioma	0.000359	0.00311	CcSEcCtD
Bupropion—Haemoglobin—Temozolomide—malignant glioma	0.000355	0.00307	CcSEcCtD
Bupropion—Haemorrhage—Temozolomide—malignant glioma	0.000353	0.00306	CcSEcCtD
Bupropion—Hepatitis—Temozolomide—malignant glioma	0.000353	0.00306	CcSEcCtD
Bupropion—Visual impairment—Carmustine—malignant glioma	0.000352	0.00305	CcSEcCtD
Bupropion—Hallucination—Temozolomide—malignant glioma	0.000351	0.00304	CcSEcCtD
Bupropion—Hypoaesthesia—Temozolomide—malignant glioma	0.000351	0.00304	CcSEcCtD
Bupropion—Pharyngitis—Temozolomide—malignant glioma	0.00035	0.00303	CcSEcCtD
Bupropion—Urinary tract disorder—Temozolomide—malignant glioma	0.000349	0.00302	CcSEcCtD
Bupropion—Oedema peripheral—Temozolomide—malignant glioma	0.000348	0.00301	CcSEcCtD
Bupropion—Connective tissue disorder—Temozolomide—malignant glioma	0.000347	0.003	CcSEcCtD
Bupropion—Urethral disorder—Temozolomide—malignant glioma	0.000346	0.003	CcSEcCtD
Bupropion—Eye disorder—Carmustine—malignant glioma	0.000341	0.00295	CcSEcCtD
Bupropion—Visual impairment—Temozolomide—malignant glioma	0.00034	0.00294	CcSEcCtD
Bupropion—Flushing—Carmustine—malignant glioma	0.000339	0.00293	CcSEcCtD
Bupropion—SLC6A3—central nervous system—malignant glioma	0.000334	0.0188	CbGeAlD
Bupropion—Erythema multiforme—Temozolomide—malignant glioma	0.000334	0.00289	CcSEcCtD
Bupropion—Eye disorder—Temozolomide—malignant glioma	0.00033	0.00286	CcSEcCtD
Bupropion—Tinnitus—Temozolomide—malignant glioma	0.000329	0.00285	CcSEcCtD
Bupropion—CYP2E1—telencephalon—malignant glioma	0.000328	0.0184	CbGeAlD
Bupropion—Flushing—Temozolomide—malignant glioma	0.000328	0.00284	CcSEcCtD
Bupropion—Cardiac disorder—Temozolomide—malignant glioma	0.000328	0.00284	CcSEcCtD
Bupropion—SLC6A3—cerebellum—malignant glioma	0.000327	0.0183	CbGeAlD
Bupropion—Arrhythmia—Carmustine—malignant glioma	0.000326	0.00282	CcSEcCtD
Bupropion—Alopecia—Carmustine—malignant glioma	0.000323	0.00279	CcSEcCtD
Bupropion—Angiopathy—Temozolomide—malignant glioma	0.00032	0.00277	CcSEcCtD
Bupropion—Mental disorder—Carmustine—malignant glioma	0.00032	0.00277	CcSEcCtD
Bupropion—Immune system disorder—Temozolomide—malignant glioma	0.000319	0.00276	CcSEcCtD
Bupropion—Mediastinal disorder—Temozolomide—malignant glioma	0.000318	0.00275	CcSEcCtD
Bupropion—Malnutrition—Carmustine—malignant glioma	0.000318	0.00275	CcSEcCtD
Bupropion—Chills—Temozolomide—malignant glioma	0.000317	0.00274	CcSEcCtD
Bupropion—CYP2A6—brain—malignant glioma	0.000313	0.0176	CbGeAlD
Bupropion—Alopecia—Temozolomide—malignant glioma	0.000312	0.0027	CcSEcCtD
Bupropion—Mental disorder—Temozolomide—malignant glioma	0.000309	0.00268	CcSEcCtD
Bupropion—Back pain—Carmustine—malignant glioma	0.000307	0.00266	CcSEcCtD
Bupropion—Malnutrition—Temozolomide—malignant glioma	0.000307	0.00266	CcSEcCtD
Bupropion—Dysgeusia—Temozolomide—malignant glioma	0.000301	0.0026	CcSEcCtD
Bupropion—Vision blurred—Carmustine—malignant glioma	0.0003	0.00259	CcSEcCtD
Bupropion—Tremor—Carmustine—malignant glioma	0.000298	0.00258	CcSEcCtD
Bupropion—Back pain—Temozolomide—malignant glioma	0.000297	0.00257	CcSEcCtD
Bupropion—Anaemia—Carmustine—malignant glioma	0.000294	0.00254	CcSEcCtD
Bupropion—CYP2D6—brainstem—malignant glioma	0.000293	0.0164	CbGeAlD
Bupropion—Agitation—Carmustine—malignant glioma	0.000292	0.00253	CcSEcCtD
Bupropion—Vision blurred—Temozolomide—malignant glioma	0.00029	0.00251	CcSEcCtD
Bupropion—Tremor—Temozolomide—malignant glioma	0.000288	0.00249	CcSEcCtD
Bupropion—Ill-defined disorder—Temozolomide—malignant glioma	0.000285	0.00247	CcSEcCtD
Bupropion—Leukopenia—Carmustine—malignant glioma	0.000285	0.00246	CcSEcCtD
Bupropion—Anaemia—Temozolomide—malignant glioma	0.000284	0.00246	CcSEcCtD
Bupropion—Agitation—Temozolomide—malignant glioma	0.000282	0.00244	CcSEcCtD
Bupropion—Angioedema—Temozolomide—malignant glioma	0.000281	0.00243	CcSEcCtD
Bupropion—Malaise—Temozolomide—malignant glioma	0.000277	0.0024	CcSEcCtD
Bupropion—Vertigo—Temozolomide—malignant glioma	0.000276	0.00239	CcSEcCtD
Bupropion—Convulsion—Carmustine—malignant glioma	0.000275	0.00238	CcSEcCtD
Bupropion—Leukopenia—Temozolomide—malignant glioma	0.000275	0.00238	CcSEcCtD
Bupropion—Hypertension—Carmustine—malignant glioma	0.000274	0.00238	CcSEcCtD
Bupropion—Palpitations—Temozolomide—malignant glioma	0.000271	0.00235	CcSEcCtD
Bupropion—Myalgia—Carmustine—malignant glioma	0.000271	0.00234	CcSEcCtD
Bupropion—Chest pain—Carmustine—malignant glioma	0.000271	0.00234	CcSEcCtD
Bupropion—Anxiety—Carmustine—malignant glioma	0.00027	0.00234	CcSEcCtD
Bupropion—SLC6A2—central nervous system—malignant glioma	0.00027	0.0151	CbGeAlD
Bupropion—Cough—Temozolomide—malignant glioma	0.000268	0.00232	CcSEcCtD
Bupropion—Convulsion—Temozolomide—malignant glioma	0.000266	0.0023	CcSEcCtD
Bupropion—SLC6A3—brain—malignant glioma	0.000265	0.0149	CbGeAlD
Bupropion—Hypertension—Temozolomide—malignant glioma	0.000265	0.0023	CcSEcCtD
Bupropion—Confusional state—Carmustine—malignant glioma	0.000262	0.00227	CcSEcCtD
Bupropion—Arthralgia—Temozolomide—malignant glioma	0.000262	0.00226	CcSEcCtD
Bupropion—Myalgia—Temozolomide—malignant glioma	0.000262	0.00226	CcSEcCtD
Bupropion—Anxiety—Temozolomide—malignant glioma	0.000261	0.00226	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00026	0.00225	CcSEcCtD
Bupropion—CYP2D6—telencephalon—malignant glioma	0.00026	0.0146	CbGeAlD
Bupropion—Oedema—Carmustine—malignant glioma	0.000259	0.00225	CcSEcCtD
Bupropion—Discomfort—Temozolomide—malignant glioma	0.000258	0.00224	CcSEcCtD
Bupropion—Infection—Carmustine—malignant glioma	0.000258	0.00223	CcSEcCtD
Bupropion—CYP2E1—medulla oblongata—malignant glioma	0.000258	0.0145	CbGeAlD
Bupropion—Dry mouth—Temozolomide—malignant glioma	0.000256	0.00221	CcSEcCtD
Bupropion—Thrombocytopenia—Carmustine—malignant glioma	0.000254	0.0022	CcSEcCtD
Bupropion—Tachycardia—Carmustine—malignant glioma	0.000253	0.00219	CcSEcCtD
Bupropion—Confusional state—Temozolomide—malignant glioma	0.000253	0.00219	CcSEcCtD
Bupropion—Oedema—Temozolomide—malignant glioma	0.000251	0.00217	CcSEcCtD
Bupropion—Anaphylactic shock—Temozolomide—malignant glioma	0.000251	0.00217	CcSEcCtD
Bupropion—Infection—Temozolomide—malignant glioma	0.000249	0.00216	CcSEcCtD
Bupropion—Anorexia—Carmustine—malignant glioma	0.000247	0.00214	CcSEcCtD
Bupropion—Nervous system disorder—Temozolomide—malignant glioma	0.000246	0.00213	CcSEcCtD
Bupropion—Thrombocytopenia—Temozolomide—malignant glioma	0.000245	0.00213	CcSEcCtD
Bupropion—Skin disorder—Temozolomide—malignant glioma	0.000244	0.00211	CcSEcCtD
Bupropion—Hypotension—Carmustine—malignant glioma	0.000242	0.0021	CcSEcCtD
Bupropion—Hyperhidrosis—Temozolomide—malignant glioma	0.000242	0.0021	CcSEcCtD
Bupropion—Anorexia—Temozolomide—malignant glioma	0.000239	0.00207	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000236	0.00205	CcSEcCtD
Bupropion—Insomnia—Carmustine—malignant glioma	0.000235	0.00203	CcSEcCtD
Bupropion—Paraesthesia—Carmustine—malignant glioma	0.000233	0.00202	CcSEcCtD
Bupropion—Dyspnoea—Carmustine—malignant glioma	0.000231	0.002	CcSEcCtD
Bupropion—Somnolence—Carmustine—malignant glioma	0.000231	0.002	CcSEcCtD
Bupropion—CYP2E1—spinal cord—malignant glioma	0.00023	0.0129	CbGeAlD
Bupropion—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000228	0.00198	CcSEcCtD
Bupropion—Insomnia—Temozolomide—malignant glioma	0.000227	0.00196	CcSEcCtD
Bupropion—Decreased appetite—Carmustine—malignant glioma	0.000226	0.00195	CcSEcCtD
Bupropion—Paraesthesia—Temozolomide—malignant glioma	0.000225	0.00195	CcSEcCtD
Bupropion—Gastrointestinal disorder—Carmustine—malignant glioma	0.000224	0.00194	CcSEcCtD
Bupropion—Dyspnoea—Temozolomide—malignant glioma	0.000224	0.00194	CcSEcCtD
Bupropion—Somnolence—Temozolomide—malignant glioma	0.000223	0.00193	CcSEcCtD
Bupropion—Constipation—Carmustine—malignant glioma	0.000222	0.00192	CcSEcCtD
Bupropion—Pain—Carmustine—malignant glioma	0.000222	0.00192	CcSEcCtD
Bupropion—Dyspepsia—Temozolomide—malignant glioma	0.000221	0.00191	CcSEcCtD
Bupropion—Decreased appetite—Temozolomide—malignant glioma	0.000218	0.00189	CcSEcCtD
Bupropion—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000216	0.00187	CcSEcCtD
Bupropion—Fatigue—Temozolomide—malignant glioma	0.000216	0.00187	CcSEcCtD
Bupropion—Pain—Temozolomide—malignant glioma	0.000214	0.00186	CcSEcCtD
Bupropion—Constipation—Temozolomide—malignant glioma	0.000214	0.00186	CcSEcCtD
Bupropion—SLC6A2—brain—malignant glioma	0.000214	0.012	CbGeAlD
Bupropion—Feeling abnormal—Carmustine—malignant glioma	0.000214	0.00185	CcSEcCtD
Bupropion—Gastrointestinal pain—Carmustine—malignant glioma	0.000212	0.00184	CcSEcCtD
Bupropion—Feeling abnormal—Temozolomide—malignant glioma	0.000207	0.00179	CcSEcCtD
Bupropion—Body temperature increased—Carmustine—malignant glioma	0.000205	0.00178	CcSEcCtD
Bupropion—Abdominal pain—Carmustine—malignant glioma	0.000205	0.00178	CcSEcCtD
Bupropion—Gastrointestinal pain—Temozolomide—malignant glioma	0.000205	0.00178	CcSEcCtD
Bupropion—Urticaria—Temozolomide—malignant glioma	0.000199	0.00172	CcSEcCtD
Bupropion—CYP2B6—central nervous system—malignant glioma	0.000199	0.0112	CbGeAlD
Bupropion—Abdominal pain—Temozolomide—malignant glioma	0.000198	0.00172	CcSEcCtD
Bupropion—Body temperature increased—Temozolomide—malignant glioma	0.000198	0.00172	CcSEcCtD
Bupropion—Hypersensitivity—Carmustine—malignant glioma	0.000191	0.00166	CcSEcCtD
Bupropion—CYP2E1—central nervous system—malignant glioma	0.000186	0.0105	CbGeAlD
Bupropion—Asthenia—Carmustine—malignant glioma	0.000186	0.00161	CcSEcCtD
Bupropion—Hypersensitivity—Temozolomide—malignant glioma	0.000185	0.0016	CcSEcCtD
Bupropion—CYP2E1—cerebellum—malignant glioma	0.000182	0.0102	CbGeAlD
Bupropion—Asthenia—Temozolomide—malignant glioma	0.00018	0.00156	CcSEcCtD
Bupropion—Diarrhoea—Carmustine—malignant glioma	0.000178	0.00154	CcSEcCtD
Bupropion—Pruritus—Temozolomide—malignant glioma	0.000177	0.00154	CcSEcCtD
Bupropion—CYP2C8—brain—malignant glioma	0.000176	0.00987	CbGeAlD
Bupropion—Dizziness—Carmustine—malignant glioma	0.000172	0.00149	CcSEcCtD
Bupropion—Diarrhoea—Temozolomide—malignant glioma	0.000172	0.00149	CcSEcCtD
Bupropion—Dizziness—Temozolomide—malignant glioma	0.000166	0.00144	CcSEcCtD
Bupropion—Vomiting—Carmustine—malignant glioma	0.000165	0.00143	CcSEcCtD
Bupropion—Rash—Carmustine—malignant glioma	0.000164	0.00142	CcSEcCtD
Bupropion—Dermatitis—Carmustine—malignant glioma	0.000163	0.00142	CcSEcCtD
Bupropion—Headache—Carmustine—malignant glioma	0.000163	0.00141	CcSEcCtD
Bupropion—Vomiting—Temozolomide—malignant glioma	0.000159	0.00138	CcSEcCtD
Bupropion—Rash—Temozolomide—malignant glioma	0.000158	0.00137	CcSEcCtD
Bupropion—Dermatitis—Temozolomide—malignant glioma	0.000158	0.00137	CcSEcCtD
Bupropion—CYP2B6—brain—malignant glioma	0.000158	0.00886	CbGeAlD
Bupropion—Headache—Temozolomide—malignant glioma	0.000157	0.00136	CcSEcCtD
Bupropion—Nausea—Carmustine—malignant glioma	0.000154	0.00133	CcSEcCtD
Bupropion—CYP3A4—central nervous system—malignant glioma	0.00015	0.00842	CbGeAlD
Bupropion—Nausea—Temozolomide—malignant glioma	0.000149	0.00129	CcSEcCtD
Bupropion—CYP2E1—brain—malignant glioma	0.000148	0.00831	CbGeAlD
Bupropion—CYP2D6—central nervous system—malignant glioma	0.000148	0.00829	CbGeAlD
Bupropion—CYP2D6—cerebellum—malignant glioma	0.000144	0.0081	CbGeAlD
Bupropion—CYP2D6—brain—malignant glioma	0.000117	0.00658	CbGeAlD
Bupropion—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	3.62e-05	0.000586	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.58e-05	0.00058	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—GSTT1—malignant glioma	3.49e-05	0.000565	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—BRAF—malignant glioma	3.44e-05	0.000557	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	3.38e-05	0.000548	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	3.31e-05	0.000536	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	3.31e-05	0.000536	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—PTGS1—malignant glioma	3.27e-05	0.00053	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ASMT—malignant glioma	3.26e-05	0.000528	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.26e-05	0.000528	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—RTEL1—malignant glioma	3.17e-05	0.000513	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.15e-05	0.000511	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	3.15e-05	0.00051	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	3.15e-05	0.00051	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—GSTP1—malignant glioma	3.14e-05	0.000508	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	3.13e-05	0.000506	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—COX8A—malignant glioma	3.1e-05	0.000501	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	3.1e-05	0.000501	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—BCAN—malignant glioma	3.07e-05	0.000496	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—COX8A—malignant glioma	3.03e-05	0.000491	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—MDM2—malignant glioma	2.89e-05	0.000467	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—RAF1—malignant glioma	2.88e-05	0.000465	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.65e-05	0.000429	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ASMT—malignant glioma	2.63e-05	0.000426	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—COX8A—malignant glioma	2.62e-05	0.000424	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ASMT—malignant glioma	2.58e-05	0.000417	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.57e-05	0.000416	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—BCAN—malignant glioma	2.47e-05	0.0004	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—IDH2—malignant glioma	2.47e-05	0.0004	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—RTEL1—malignant glioma	2.45e-05	0.000396	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—BCAN—malignant glioma	2.42e-05	0.000392	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—GSTP1—malignant glioma	2.42e-05	0.000392	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	2.39e-05	0.000387	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.34e-05	0.000379	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP2B6—malignant glioma	2.32e-05	0.000376	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.27e-05	0.000367	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ASMT—malignant glioma	2.23e-05	0.000361	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.19e-05	0.000355	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.18e-05	0.000352	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—COX8A—malignant glioma	2.15e-05	0.000348	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—COX8A—malignant glioma	2.13e-05	0.000345	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—IDH1—malignant glioma	2.13e-05	0.000344	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—BCAN—malignant glioma	2.09e-05	0.000339	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—SPHK1—malignant glioma	2.06e-05	0.000333	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP2C18—malignant glioma	2.02e-05	0.000326	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—IDH2—malignant glioma	1.99e-05	0.000323	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—IDH2—malignant glioma	1.95e-05	0.000316	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.91e-05	0.000309	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP2B6—malignant glioma	1.84e-05	0.000297	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ASMT—malignant glioma	1.83e-05	0.000296	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—COX8A—malignant glioma	1.82e-05	0.000295	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ASMT—malignant glioma	1.81e-05	0.000293	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.77e-05	0.000287	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.75e-05	0.000282	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—BCAN—malignant glioma	1.72e-05	0.000278	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—IDH1—malignant glioma	1.72e-05	0.000278	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—BCAN—malignant glioma	1.7e-05	0.000276	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—IDH2—malignant glioma	1.69e-05	0.000273	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—IDH1—malignant glioma	1.68e-05	0.000272	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—SPHK1—malignant glioma	1.66e-05	0.000269	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTT1—malignant glioma	1.63e-05	0.000264	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.63e-05	0.000264	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP2C18—malignant glioma	1.63e-05	0.000263	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—SPHK1—malignant glioma	1.63e-05	0.000263	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP2C18—malignant glioma	1.59e-05	0.000258	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.59e-05	0.000258	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP2B6—malignant glioma	1.59e-05	0.000257	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ASMT—malignant glioma	1.55e-05	0.000251	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—RAF1—malignant glioma	1.55e-05	0.00025	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTGS1—malignant glioma	1.53e-05	0.000247	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.51e-05	0.000245	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—BCAN—malignant glioma	1.46e-05	0.000236	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—IDH1—malignant glioma	1.45e-05	0.000235	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—BCHE—malignant glioma	1.42e-05	0.00023	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—COX8A—malignant glioma	1.41e-05	0.000228	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—SPHK1—malignant glioma	1.41e-05	0.000227	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—SLC5A5—malignant glioma	1.4e-05	0.000227	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—IDH2—malignant glioma	1.39e-05	0.000224	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP2C18—malignant glioma	1.38e-05	0.000223	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—IDH2—malignant glioma	1.37e-05	0.000222	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTT1—malignant glioma	1.31e-05	0.000213	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.3e-05	0.000211	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.3e-05	0.00021	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.3e-05	0.00021	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.29e-05	0.000209	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTT1—malignant glioma	1.29e-05	0.000208	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTGS1—malignant glioma	1.23e-05	0.000199	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTGS1—malignant glioma	1.21e-05	0.000195	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ASMT—malignant glioma	1.2e-05	0.000194	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—IDH1—malignant glioma	1.19e-05	0.000193	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.18e-05	0.000191	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—IDH1—malignant glioma	1.18e-05	0.000191	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—IDH2—malignant glioma	1.17e-05	0.00019	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—SPHK1—malignant glioma	1.15e-05	0.000187	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—BCHE—malignant glioma	1.15e-05	0.000185	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—SPHK1—malignant glioma	1.14e-05	0.000185	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.14e-05	0.000185	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.13e-05	0.000183	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.13e-05	0.000183	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTP1—malignant glioma	1.13e-05	0.000183	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—BCAN—malignant glioma	1.12e-05	0.000182	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—BCHE—malignant glioma	1.12e-05	0.000182	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.12e-05	0.000181	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTT1—malignant glioma	1.11e-05	0.00018	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—SLC5A5—malignant glioma	1.11e-05	0.000179	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.11e-05	0.000179	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.1e-05	0.000179	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CAT—malignant glioma	1.1e-05	0.000178	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.06e-05	0.000171	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTGS1—malignant glioma	1.04e-05	0.000169	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.04e-05	0.000168	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—NCOR1—malignant glioma	1.04e-05	0.000168	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—IDH1—malignant glioma	1.01e-05	0.000163	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—SPHK1—malignant glioma	9.77e-06	0.000158	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—BCHE—malignant glioma	9.7e-06	0.000157	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.62e-06	0.000156	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—SLC5A5—malignant glioma	9.58e-06	0.000155	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP2C18—malignant glioma	9.57e-06	0.000155	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.29e-06	0.00015	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTT1—malignant glioma	9.14e-06	0.000148	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTP1—malignant glioma	9.11e-06	0.000147	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—IDH2—malignant glioma	9.06e-06	0.000147	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTT1—malignant glioma	9.06e-06	0.000147	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.06e-06	0.000147	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.03e-06	0.000146	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.98e-06	0.000145	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTP1—malignant glioma	8.93e-06	0.000144	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CAT—malignant glioma	8.87e-06	0.000144	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CAT—malignant glioma	8.69e-06	0.000141	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTGS1—malignant glioma	8.56e-06	0.000139	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP2B6—malignant glioma	8.52e-06	0.000138	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTGS1—malignant glioma	8.49e-06	0.000137	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CAV1—malignant glioma	8.46e-06	0.000137	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.46e-06	0.000137	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—NCOR1—malignant glioma	8.38e-06	0.000136	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.22e-06	0.000133	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—NCOR1—malignant glioma	8.2e-06	0.000133	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—BCHE—malignant glioma	7.96e-06	0.000129	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.94e-06	0.000128	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—BCHE—malignant glioma	7.89e-06	0.000128	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—SLC5A5—malignant glioma	7.86e-06	0.000127	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.83e-06	0.000127	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—SLC5A5—malignant glioma	7.8e-06	0.000126	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—IDH1—malignant glioma	7.79e-06	0.000126	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTT1—malignant glioma	7.74e-06	0.000125	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTP1—malignant glioma	7.72e-06	0.000125	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CG—malignant glioma	7.71e-06	0.000125	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—SPHK1—malignant glioma	7.54e-06	0.000122	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CAT—malignant glioma	7.51e-06	0.000122	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PPARG—malignant glioma	7.44e-06	0.00012	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.39e-06	0.00012	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.37e-06	0.000119	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.31e-06	0.000118	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTGS1—malignant glioma	7.26e-06	0.000117	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.23e-06	0.000117	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—NCOR1—malignant glioma	7.09e-06	0.000115	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CAV1—malignant glioma	6.83e-06	0.00011	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CD—malignant glioma	6.78e-06	0.00011	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—BCHE—malignant glioma	6.74e-06	0.000109	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CAV1—malignant glioma	6.69e-06	0.000108	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—SLC5A5—malignant glioma	6.66e-06	0.000108	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.37e-06	0.000103	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTP1—malignant glioma	6.33e-06	0.000103	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.3e-06	0.000102	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTP1—malignant glioma	6.28e-06	0.000102	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.24e-06	0.000101	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CG—malignant glioma	6.22e-06	0.000101	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CAT—malignant glioma	6.16e-06	9.98e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CAT—malignant glioma	6.11e-06	9.89e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CG—malignant glioma	6.09e-06	9.86e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PPARG—malignant glioma	6e-06	9.71e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTT1—malignant glioma	5.98e-06	9.67e-05	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CB—malignant glioma	5.91e-06	9.56e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PPARG—malignant glioma	5.88e-06	9.51e-05	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTGS2—malignant glioma	5.85e-06	9.47e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—NCOR1—malignant glioma	5.82e-06	9.42e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CAV1—malignant glioma	5.78e-06	9.35e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NCOR1—malignant glioma	5.77e-06	9.34e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTGS1—malignant glioma	5.6e-06	9.06e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.52e-06	8.94e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CD—malignant glioma	5.47e-06	8.85e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.44e-06	8.81e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTP1—malignant glioma	5.37e-06	8.68e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CD—malignant glioma	5.36e-06	8.67e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CG—malignant glioma	5.27e-06	8.52e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CAT—malignant glioma	5.22e-06	8.45e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—BCHE—malignant glioma	5.21e-06	8.42e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.14e-06	8.32e-05	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTEN—malignant glioma	5.1e-06	8.26e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PPARG—malignant glioma	5.08e-06	8.22e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NCOR1—malignant glioma	4.93e-06	7.98e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CB—malignant glioma	4.77e-06	7.71e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CAV1—malignant glioma	4.75e-06	7.68e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTGS2—malignant glioma	4.72e-06	7.64e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CAV1—malignant glioma	4.7e-06	7.61e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CB—malignant glioma	4.67e-06	7.55e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CD—malignant glioma	4.63e-06	7.49e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTGS2—malignant glioma	4.62e-06	7.48e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.49e-06	7.27e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.32e-06	7e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.29e-06	6.93e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PPARG—malignant glioma	4.17e-06	6.75e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTP1—malignant glioma	4.14e-06	6.7e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PPARG—malignant glioma	4.14e-06	6.69e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTEN—malignant glioma	4.12e-06	6.66e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CB—malignant glioma	4.03e-06	6.53e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTEN—malignant glioma	4.03e-06	6.53e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CAT—malignant glioma	4.03e-06	6.52e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CAV1—malignant glioma	4.02e-06	6.51e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTGS2—malignant glioma	4e-06	6.47e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.84e-06	6.22e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NCOR1—malignant glioma	3.81e-06	6.16e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.8e-06	6.15e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.77e-06	6.1e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.66e-06	5.93e-05	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CA—malignant glioma	3.6e-06	5.83e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PPARG—malignant glioma	3.53e-06	5.72e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTEN—malignant glioma	3.49e-06	5.64e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.31e-06	5.36e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.28e-06	5.31e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTGS2—malignant glioma	3.28e-06	5.31e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTGS2—malignant glioma	3.25e-06	5.27e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.22e-06	5.21e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CAV1—malignant glioma	3.1e-06	5.02e-05	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—AKT1—malignant glioma	2.94e-06	4.76e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.91e-06	4.7e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTEN—malignant glioma	2.86e-06	4.63e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CA—malignant glioma	2.85e-06	4.6e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTEN—malignant glioma	2.84e-06	4.59e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.83e-06	4.57e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.81e-06	4.54e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTGS2—malignant glioma	2.78e-06	4.5e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PPARG—malignant glioma	2.73e-06	4.41e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.48e-06	4.02e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.46e-06	3.98e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTEN—malignant glioma	2.42e-06	3.92e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—AKT1—malignant glioma	2.37e-06	3.84e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—AKT1—malignant glioma	2.32e-06	3.76e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.17e-06	3.5e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTGS2—malignant glioma	2.15e-06	3.47e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.02e-06	3.27e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—AKT1—malignant glioma	2.01e-06	3.25e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CA—malignant glioma	2e-06	3.24e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTEN—malignant glioma	1.87e-06	3.03e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.71e-06	2.77e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—AKT1—malignant glioma	1.65e-06	2.67e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—AKT1—malignant glioma	1.64e-06	2.65e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—AKT1—malignant glioma	1.4e-06	2.26e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.32e-06	2.14e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—AKT1—malignant glioma	1.08e-06	1.75e-05	CbGpPWpGaD
